Mesa Laboratories opened lower at $138.39, compared with its previous close of $139.21. In the last trading session, the stock traded between $130.81 and $139.94. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Mesa Laboratories is now worth
$ 43.01
Resulting in a loss of
$ 56.99 (56.99%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 1 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-4.09 (-2.94%)
Day High
$139.94
Day Low
$130.81
Day Open
$138.39
Prev Close
$139.21
Volume
92,006
1W Return
6.61%
1M Return
5.51%
3M Return
21.34%
6M Return
31.33%
1Y Return
68.80%
Fundamentals
Market Cap ($ Mn)
760
PE Ratio
151.62
PB Ratio
3.82
PEG Ratio
75.94
ROE
-1.28%
ROCE
5.43%
EPS (TTM)
$0.77
Investment Returns
1 Week
6.61%
1 Month
5.51%
3 Months
21.34%
6 Months
31.33%
9 Months
48.11%
Financials
Quarterly
All values in $ Mn
59.5
Jun 25
60.7
Sep 25
65.1
Dec 25
63.7
Mar 26
60.1
Jun 26
62.3
Sep 26
Updates
11Nov
Jefferies raises Mesa Laboratories price target to $150, keeps Buy
Jefferies raises Mesa Laboratories price target from $125 to $150. Analyst Tycho Peterson maintains a Buy rating on the stock. The new target implies a 20% increase from the previous estimate.
2 days ago
10Nov
Mesa Labs Q2FY27 Results: Net income up 75%, FY27 sales guide below est
Net income rose 75.3% to $4.34 million in Q2FY27. FY2027 revenue guidance of $250M-$255M trails $254.45M analyst estimate. Sterilization division revenue up 14.6%; Clinical Genomics down 8.8%. Adjusted EBITDA expanded 21.1% to $17.32 million despite modest revenue growth.
3 days ago
13Oct
Mesa Labs plans $9.3M cost cuts via global restructuring
Gross annualized operating cost reduction targeted at ~$9.3 million. Net annualized cost reduction stands at ~$5.0 million after reinvestment. Pre-tax restructuring charges estimated at $2.6 million to $3.4 million. Full reflection in cost structure expected by end of fiscal year 2028.
1mo ago
10Oct
Mesa Laboratories declares $0.16 per share quarterly dividend for Dec 2026
Mesa Laboratories declared a regular quarterly dividend of $0.16 per share. Payment date is set for December 15, 2026. Shareholders of record as of November 30, 2026 are eligible for the payout.
1mo ago
11Aug
Mesa Laboratories Q1 Adj EPS beats estimates by 11.67%
Mesa Laboratories delivered a strong earnings beat in Q1 with adjusted EPS of $2.68, exceeding estimates by 11.67%. While sales of $60.138 million missed consensus by 1.20%, they showed a 1% YoY increase.
3mo ago
11Aug
Mesa Labs Q1 Results: Operating Income Jumps 129% To $7,031
Mesa Laboratories delivered strong operational results in 1Q27, with adjusted operating income excluding unusual items rising 19.5% to $15.4 million. Revenues grew 1.0% organically to $60.1 million, led by Calibration Solutions and Biopharmaceutical Development. The company repaid $8.6 million in debt, lowering its leverage ratio to 1.85.
